These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 18035721)
41. Comparison of one-dimensional and two-dimensional gel electrophoresis as a separation tool for proteomic analysis of rat liver microsomes: cytochromes P450 and other membrane proteins. Galeva N; Altermann M Proteomics; 2002 Jun; 2(6):713-22. PubMed ID: 12112853 [TBL] [Abstract][Full Text] [Related]
42. Multiple-approaches to the identification and quantification of cytochromes P450 in human liver tissue by mass spectrometry. Seibert C; Davidson BR; Fuller BJ; Patterson LH; Griffiths WJ; Wang Y J Proteome Res; 2009 Apr; 8(4):1672-81. PubMed ID: 19714871 [TBL] [Abstract][Full Text] [Related]
43. Cytochromes P450--a family of proteins and scientists-understanding their relationships. Sue Masters B; Marohnic CC Drug Metab Rev; 2006; 38(1-2):209-25. PubMed ID: 16684658 [TBL] [Abstract][Full Text] [Related]
44. Optimization and validation of a label-free MRM method for the quantification of cytochrome P450 isoforms in biological samples. Al Ali A; Touboul D; Le Caër JP; Schmitz-Afonso I; Flinois JP; Marchetti C; De Waziers I; Brunelle A; Laprévote O; Beaune P Anal Bioanal Chem; 2014 Aug; 406(20):4861-74. PubMed ID: 24952904 [TBL] [Abstract][Full Text] [Related]
45. Sulfenylation of Human Liver and Kidney Microsomal Cytochromes P450 and Other Drug-Metabolizing Enzymes as a Response to Redox Alteration. Albertolle ME; Phan TTN; Pozzi A; Guengerich FP Mol Cell Proteomics; 2018 May; 17(5):889-900. PubMed ID: 29374135 [TBL] [Abstract][Full Text] [Related]
46. Chromatographic separation and behavior of microsomal cytochrome P450 and cytochrome b5. Roos PH J Chromatogr B Biomed Appl; 1996 Sep; 684(1-2):107-31. PubMed ID: 8906469 [TBL] [Abstract][Full Text] [Related]
47. Age but not gender selectively affects expression of individual cytochrome P450 proteins in human liver. George J; Byth K; Farrell GC Biochem Pharmacol; 1995 Aug; 50(5):727-30. PubMed ID: 7669077 [TBL] [Abstract][Full Text] [Related]
48. Rational Development of Novel Activity Probes for the Analysis of Human Cytochromes P450. Sellars JD; Skipsey M; Sadr-Ul-Shaheed ; Gravell S; Abumansour H; Kashtl G; Irfan J; Khot M; Pors K; Patterson LH; Sutton CW ChemMedChem; 2016 Jun; 11(11):1122-8. PubMed ID: 27154431 [TBL] [Abstract][Full Text] [Related]
49. Combination of on-line CE assay with MS detection for the study of drug metabolism by cytochromes P450. Langmajerová M; Řemínek R; Pelcová M; Foret F; Glatz Z Electrophoresis; 2015 Jun; 36(11-12):1365-73. PubMed ID: 25735735 [TBL] [Abstract][Full Text] [Related]
51. In vivo evaluation of effect of anthocyanin-rich wheat on rat liver microsomal drug-metabolizing cytochromes P450 and on biochemical and antioxidant parameters in rats. Prokop J; Anzenbacher P; Mrkvicová E; Pavlata L; Zapletalová I; Šťastník O; Martinek P; Kosina P; Anzenbacherová E Food Chem Toxicol; 2018 Dec; 122():225-233. PubMed ID: 30316842 [TBL] [Abstract][Full Text] [Related]
52. Expression of Cytochromes P-450 2E1, 3A4 and 1A1/1A2 in Growing and Confluent Human HepG2 Hepatoma Cells-Effect of Ethanol. Alexandre E; David P; Viollon C; Wolf P; Jaeck D; Azimzadeh A; Nicod L; Boudjema K; Richert L Toxicol In Vitro; 1999 Jun; 13(3):427-35. PubMed ID: 20654500 [TBL] [Abstract][Full Text] [Related]
53. Identification of cytochrome P450 enzymes in human colorectal metastases and the surrounding liver: a proteomic approach. Lane CS; Nisar S; Griffiths WJ; Fuller BJ; Davidson BR; Hewes J; Welham KJ; Patterson LH Eur J Cancer; 2004 Sep; 40(14):2127-34. PubMed ID: 15341988 [TBL] [Abstract][Full Text] [Related]
54. Peptide-Mediated Specific Immobilization of Catalytically Active Cytochrome P450 BM3 Variant. Zernia S; Ott F; Bellmann-Sickert K; Frank R; Klenner M; Jahnke HG; Prager A; Abel B; Robitzki A; Beck-Sickinger AG Bioconjug Chem; 2016 Apr; 27(4):1090-7. PubMed ID: 26967204 [TBL] [Abstract][Full Text] [Related]
55. Direct Quantification of Cytochromes P450 and Drug Transporters-A Rapid, Targeted Mass Spectrometry-Based Immunoassay Panel for Tissues and Cell Culture Lysates. Weiß F; Hammer HS; Klein K; Planatscher H; Zanger UM; Norén A; Wegler C; Artursson P; Joos TO; Poetz O Drug Metab Dispos; 2018 Apr; 46(4):387-396. PubMed ID: 29343608 [TBL] [Abstract][Full Text] [Related]
56. Comparative cytochrome P450 proteomics in the livers of immunodeficient mice using 18O stable isotope labeling. Lane CS; Wang Y; Betts R; Griffiths WJ; Patterson LH Mol Cell Proteomics; 2007 Jun; 6(6):953-62. PubMed ID: 17296599 [TBL] [Abstract][Full Text] [Related]
57. Applying of hierarchical clustering to analysis of protein patterns in the human cancer-associated liver. Petushkova NA; Pyatnitskiy MA; Rudenko VA; Larina OV; Trifonova OP; Kisrieva JS; Samenkova NF; Kuznetsova GP; Karuzina II; Lisitsa AV PLoS One; 2014; 9(8):e103950. PubMed ID: 25083712 [TBL] [Abstract][Full Text] [Related]
58. Cytochromes P450 in crustacea. James MO; Boyle SM Comp Biochem Physiol C Pharmacol Toxicol Endocrinol; 1998 Nov; 121(1-3):157-72. PubMed ID: 9972457 [TBL] [Abstract][Full Text] [Related]
59. Immunochemical analysis of cytochrome P450 variability in human leukapheresed samples and its consequences for the risk assessment process. Bernauer U; Garritsen H; Heinrich-Hirsch B; Gundert-Remy U Regul Toxicol Pharmacol; 2003 Apr; 37(2):318-27. PubMed ID: 12726760 [TBL] [Abstract][Full Text] [Related]